Safety and tolerability of Magrolimab combinations in patients with relapsed/refractory multiple myeloma (RRMM): Safety run-in results from a phase 2 Study Meeting Abstract


Authors: Paul, B.; Minarík, J.; Cottini, F.; Gasparetto, C.; Khouri, J.; Gandhi, M.; Hillengass, J.; Levy, M.; Liedtke, M.; Manda, S.; Sandhu, I.; Sborov, D.; Spicka, I.; Usmani, S. Z.; Gu, L.; Robeson, M.; Murphy, M.; Renard, C.; Chen, C.; Pour, L.
Abstract Title: Safety and tolerability of Magrolimab combinations in patients with relapsed/refractory multiple myeloma (RRMM): Safety run-in results from a phase 2 Study
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-02
Start Page: 3383
Language: English
ACCESSION: WOS:001159740303246
DOI: 10.1182/blood-2023-186997
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Saad Zafar Usmani
    296 Usmani
Related MSK Work